Authors
Loading...
Randomized trial demonstrates improved antimicrobial peptide design in drug-resistant pathogens, suggesting significant therapeutic advancements.
Liu et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: